Cytomx Therapeutics, Inc. · NASDAQ:CTMX
The Vanguard Group reported a 5.95% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.95% stake in Cytomx Therapeutics, Inc., 9,379,794 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 5.95%
- Shares
- 9,379,794
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.95% | 9,379,794 |
Source
Related
- Cytomx Therapeutics, Inc.
- The Vanguard Group
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026